No shortage on file

MULTI 12

SANDOZ CANADA INCORPORATED

Quick answers

Is there a shortage of MULTI 12 in Canada?

No. There is no current shortage of MULTI 12 660UNIT 8MG 0.8MG 20MG 3MG 80MCG 2UNIT 12MCG 0.6MG 1MCG 40UNIT 0.72MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on fileNone found

Checked by MedShort2026-11-12

DIN

02100606

Strength

660UNIT 8MG 0.8MG 20MG 3MG 80MCG 2UNIT 12MCG 0.6MG 1MCG 40UNIT 0.72MG

Dosage Form

SOLUTION LIQUID

Route

INTRAVENOUS

Active Ingredient

VITAMIN A NICOTINAMIDE PYRIDOXINE HYDROCHLORIDE ASCORBIC ACID DEXPANTHENOL FOLIC ACID VITAMIN E BIOTIN VITAMIN B1 VITAMIN B12 VITAMIN D VITAMIN B2

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2026-10-06

Resolved

Other (Please describe in comments)

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929